Tag: Medipix3

  • MARS Bioimaging partners with the Hospital for Special Surgery (HSS)

    MARS Bioimaging partners with the Hospital for Special Surgery (HSS)

    The partnership will assess particular aspects of the MARS 5×120 Extremity scanner. Read the original press release on the HSS website or our partner MBI’s website. Hospital for Special Surgery (HSS), the world’s leading academic medical center specialized in musculoskeletal health, and New Zealand-based medical device and technology company MARS Bioimaging Limited (MARS) today announced…

    Explore →

  • Spectroscopic X-ray imaging now certified for medical use

    Spectroscopic X-ray imaging now certified for medical use

    The CERN Workshops on Medical Applications of Spectroscopic X-ray Detectors have been instrumental in advancing spectroscopic X-ray imaging and bringing it from the lab to the clinic BROKEN IMAGE NOT MOVED (drupal url : https://medipix.web.cern.ch//news/news/medipix3/spectroscopic-x-ray-imaging-now-certified-medical-use) The sixth Workshop on Medical Applications of Spectroscopic X-ray Detectors is currently taking place at CERN. Launched in 2011 and…

    Explore →

  • CERN’s impact on medical technology

    CERN’s impact on medical technology

    Frontier instruments like the LHC and its detectors not only push back the boundaries of our knowledge, but also catalyse innovative technology for medical applications, writes Manuela Cirilli. This article was originally published in the July/August edition of CERN Courier magazine. Today, the tools of experimental particle physics are ubiquitous in hospitals and biomedical research.…

    Explore →

  • First European hospital receives 3D colour X-ray scanner using CERN technology

    First European hospital receives 3D colour X-ray scanner using CERN technology

    MARS Bioimaging’s 3D colour X-ray scanner has arrived in Europe to undertake clinical trials that will lead to its medical use. After years of development in New Zealand, MARS Bioimaging’s 3D colour X-ray scanner has arrived in Europe, at Lausanne University Hospital (CHUV) in Switzerland. This event marks the first step towards the European part…

    Explore →

  • Specifications

    Specifications

    Explore →

  • Features & Applications

    Features & Applications

    Features & Applications Features: Applications:

    Explore →

  • Timepix-based detectors bring particle physics in the classroom

    Timepix-based detectors bring particle physics in the classroom

    The ADMIRA project uses Timepix-based detectors to help students experiment with particle physics and contributes to transforming STEM education. Combustion, diffraction, magnetism… Many natural phenomena can be observed, experimented with and studied at school. Some have traditionally been difficult to demonstrate and have had to rely on theory only. Particle physics is one such subject…

    Explore →

  • New 3D colour X-rays made possible with CERN technology

    New 3D colour X-rays made possible with CERN technology

    Stunning new images pave the way to large-scale human trials, two years on from the first ever 3D colour human X-ray using CERN Medipix3 technology Two years after the first ever 3D colour X-ray of a living human, MARS Bioimaging have released stunning new images made using a world-first compact scanner, based on Medipix3 technology…

    Explore →

  • CERN technology helps rediscover lost painting by Raphael

    CERN technology helps rediscover lost painting by Raphael

    CERN’s Timepix particle detectors, developed by the Medipix2 Collaboration, help unravel the secret of a long-lost painting by the great Renaissance master, Raphael 500 years ago, the Italian painter Raphael passed away, leaving behind him many works of art, paintings, frescoes and engravings. Like his contemporaries Michelangelo and Leonardo da Vinci, Raphael’s work made the…

    Explore →

  • MARS Bioimaging is seeking partners to better enable drug development and therapy monitoring for COVID-19

    MARS Bioimaging is seeking partners to better enable drug development and therapy monitoring for COVID-19

    The current standard for definitive diagnosis of COVID-19 is the real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Background The current standard for definitive diagnosis of COVID-19 is the real-time reverse transcriptase-polymerase chain reaction (RT-PCR). While this is a highly sensitive and specific test for COVID-19, it does not measure the severity nor progress of the associated…

    Explore →